Evidence map›Paper›PMID 35194697›Full record

ArticleArchives of microbiology2022

Isolation and molecular identification of native As-resistant bacteria: As(III) and As(V) removal capacity and possible mechanism of detoxification.

U E Rodríguez-Castrejón, A H Serafin-Muñoz, A Alvarez-Vargas, G Cruz-Jímenez, B Noriega-Luna

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

U E Rodríguez-CastrejónDivision of Engineering, Guanajuato Campus of the University of Guanajuato, Guanajuato, Mexico.
A H Serafin-MuñozDivision of Engineering, Guanajuato Campus of the University of Guanajuato, Guanajuato, Mexico. sermuah@ugto.mx.ORCID http://orcid.org/0000-0003-3860-8508
A Alvarez-VargasDivision of Natural and Exact Sciences, Guanajuato Campus of the University of Guanajuato, Guanajuato, Mexico.
G Cruz-JímenezDivision of Natural and Exact Sciences, Guanajuato Campus of the University of Guanajuato, Guanajuato, Mexico.
B Noriega-LunaDivision of Engineering, Guanajuato Campus of the University of Guanajuato, Guanajuato, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of arsenic (As)-resistant microorganisms with high As removal capacity is fundamental for the development of economically sustainable technologies used for the treatment of water contaminated with metalloid. In the current study, four bacterial strains were isolated from As-contaminated water samples of the Xichu region, Mexico. Based on 16S rRNA gene sequencing and phylogenetic analysis of the isolated strains, Rhodococcus gordoniae, Microbacterium hydrocarbonoxydans, Exiguobacterium indicum, and Pseudomonas kribbensis were identified as potential As removal strains. R. gordoniae shows the highest growth capacity in both As(III) and As(V). R. gordoniae, M. hydrocarbonoxydans, and E. indicum removed approximately 81.6, 79.9, and 61.7% of As(III), as well as 77.2, 68.9, and 74.8% of As(V), respectively. P. kribbensis removed only about 80.2% of As(V). This study contributes to the possible detoxification mechanisms employed by these bacteria. Such insight could be crucial in the successful implementation of in situ bioremediation programs using these little-known bacteria.

Indexed as

ActinomycetalesArsenicSoil PollutantsBiodegradation, EnvironmentalPhylogenyRNA, Ribosomal, 16SArsenicRNA, Ribosomal, 16SSoil PollutantsAioArrArs CExiguobacterium indicumMicrobacterium hydrocarbonoxydansPseudomonas kribbensisRhodococcus gordoniaeXichu

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.